Oxidative stress due to aluminum exposure induces eryptosis which is prevented by erythropoietin

Journal of Cellular Biochemistry

Volumn 113, Issue 5, 2012, Pages 1581-1589

  Vota, Daiana M ^a,b   Crisp, Renée L ^a,c   Nesse, Alcira B ^a,b   Vittori, Daniela C ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c HOSPITAL NACIONAL PROFESOR ALEJANDRO POSADAS   (Argentina)

Author keywords

aluminum; erythrocytes; erythropoietin; oxidative stress

Indexed keywords

ACETYLCYSTEINE; ALUMINUM; CALCIUM; GLUTATHIONE; PHOSPHATIDYLSERINE; REACTIVE OXYGEN METABOLITE; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; CALCIUM CELL LEVEL; CELL DEATH; CELL MEMBRANE; CELL PROTECTION; CELL SHAPE; CELL STRUCTURE; CELL SURFACE; CONTROLLED STUDY; ERYPTOSIS; ERYTHROCYTE; ERYTHROID CELL; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; NORMAL HUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ADULT; ALUMINUM; ANEMIA; ANION EXCHANGE PROTEIN 1, ERYTHROCYTE; ERYTHROCYTE AGING; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; ERYTHROPOIETIN; HUMANS; MICROSCOPY, ELECTRON, SCANNING; OXIDATIVE STRESS; RECOMBINANT PROTEINS;

EID: 84859064936     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24026     Document Type: Article

References (47)

1. Abreo K, Brown ST, Sella M, Trapp G,. 1989. Application of an erythrocyte aluminum assay in the diagnosis of aluminum-associated microcytic anemia in patients undergoing dialysis and response to deferoxamine therapy. J Labor Clin Med 113: 50-57. (Pubitemid 19035183)
2. Altmann P, Plowman D, Marsh F, Cunningham J,. 1988. Aluminium chelation therapy in dialysis patients: Evidence for inhibition of haemoglobin synthesis by low levels of aluminium. Lancet i: 1012-1015.
3. Becaria A, Campbell A, Bondy SC,. 2002. Aluminum as a toxicant. Toxicol Ind Health 18: 309-320. (Pubitemid 38352147)
4. Bevers EM, Williamson PL,. 2010. Phospholipid scramblase: An update. FEBS Lett 584: 2724-2730.
5. Bohrer D, Bertagnolli DC, de Oliveira SMR, do Nascimento PC, de Carvalho LM, García SC, Arantes LC, Barros EJG,. 2009. Role of medication in the level of aluminium in the blood of chronic haemodialysis patients. Nephrol Dial Transplant 24: 1277-1281.
6. Bohrer D, de Oliveira SM, Garcia SC, do Nascimento PC, de Carvalho LM,. 2010. Aluminum loading in preterm neonates revisited. J Pediatr Gastroenterol Nutr 51: 237-241.
7. Bondy SC, Campbell A,. 2001. Oxidative and inflammatory properties of aluminium: Possible relevance in Alzheimer's disease. In:, Exley C, editor. Aluminium and Alzheimer's disease. The science that describes the link. Amsterdam: Elsevier; pp 311-321.
8. Bonomini M, Sirolli V, Sttefrati N, Dottori S, Di Liberato L, Arduini A,. 1999. Increased erythrocyte phosphatidylserine exposure in chronic renal failure. J Am Soc Nephrol 10: 1982-1990. (Pubitemid 29402520)
9. Bordin L, Fiore C, Zen F, Coleman MD, Ragazzi E, Clari G,. 2010. Dapsone hydroxylamine induces premature removal of human erythrocytes by membrane reorganization and antibody binding. Br J Pharmacol 161: 1186-1199.
10. Burrell SA, Exley C,. 2010. There is (still) too much aluminium in infant formulas. BMC Pediatr 10: 63-66.
11. Chattopadhyay A, Choudhury TD, Bandyopadhyay D, Datta AG,. 2000. Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical. Biochem Pharmacol 59: 419-425. (Pubitemid 30015971)
12. Chmielnicka J, Nasiadek M, Lewandowska-Zyndul E,. 1994. The effect of aluminum chloride on some steps of heme biosynthesis in rats after oral exposure. Biol Trace Elem Res 40: 127-136. (Pubitemid 24075403)
13. Daugas E, Candé C, Kroemer G,. 2001. Erythrocytes: Death of a mummy. Cell Death Differ 8: 1131-1133. (Pubitemid 34048467)
14. Elliot HL, McDougall AI,. 1978. Aluminum studies in dialysis encephalophathy. Proc Eur Dialysis Transplant Assoc 15: 157-163.
15. Eschbach JW, Adamson JW,. 1985. Anemia of end-stage renal disease (ESRD). Kidney Int 28: 1-5. (Pubitemid 15023016)
16. Garbossa G, Gálvez G, Castro ME, Nesse A,. 1998a. Oral aluminum administration to rats with normal renal function. 1. Impairment of erythropoiesis. Human Exp Toxicol 17: 312-317. (Pubitemid 28342339)
17. Garbossa G, Gálvez G, Pérez G, Stripeikis J, Tudino M, Nesse A,. 1998b. Oral aluminum administration to rats with normal renal function. 2. Body distribution. Human Exp Toxicol 17: 312-317. (Pubitemid 28342339)
18. Ghoti H, Amer J, Winder A, Rachmilewitz E, Fibach E,. 2007. Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome. Eur J Haematol 79: 463-467. (Pubitemid 350126678)
19. Kan WC, Chien CC, Wu CC, Su SB, Hwang JC, Wang HY,. 2010. Comparison of low-dose deferoxamine versus standard-dose deferoxamine for treatment of aluminium overload among haemodialysis patients. Nephrol Dial Transplant 25: 1604-1608.
20. Kay MMB, Flowers N, Goodman J, Bosman G,. 1989. Alteration in membrane protein band 3 associated with accelerated erythrocyte aging. Proc Natl Acad Sci (USA) 86: 5834-5838. (Pubitemid 19217544)
21. Lang F, Lang K, Lang P, Huber S, Wieder T,. 2006. Osmotic shock-induced suicidal death of erythrocytes. Acta Physiol 187: 191-198. (Pubitemid 43828776)
22. Lowry OH, Roseborough NJ, Farr AL, Randall RL,. 1951. Protein measurement with the Folin phenol reagent. Biol Chem 193: 267-275.
23. Matarrese P, Straface E, Pietraforte D, Gambardella L, Vona R, Maccaglia A, Minetti M, Malorni W,. 2005. Peroxynitrite induces senescence and apoptosis of red blood cells through the activation of aspartyl and cysteinyl proteases. FASEB J 19: 416-418. (Pubitemid 40316535)
24. Metere A, Iorio E, Petraforte D, Podo F, Minetti M,. 2009. Peroxynitrite signalling in human erythrocytes: Synergistic role of haemoglobin oxidation and band 3 tyrosine phosphorylation. Arch Biochem Biophys 484: 173-182.
25. Morgan J, Morton H, Parker R,. 1950. Nutrition of animal cells in tissue culture. I. Initial studies on a synthetic medium. Proc Soc Exp Biol Med 73: 1-8.
26. Mujika JI, Ruipérez F, Infante I, Ugalde JM, Exley C, Lopez X,. 2011. Pro-oxidant activity of aluminium: Stabilization of the aluminum superoxide radical ion. J Phys Chem 115: 6717-6723.
27. Mundy WR, Shafer TJ,. 2001. Aluminium-induced alteration of phosphoinositide and calcium signalling. In:, Exley C, editor. Aluminium and Alzheimer's disease. The science that describes the link. Amsterdam: Elsevier; pp 345-360.
28. Myssina S, Huber SM, Birka C, Lang PA, Lang KS, Friedrich B, Risler T, Wieder T, Lang F,. 2003. Inhibition of erythrocyte cation channels by erythropoietin. J Am Soc Nephrol 14: 2750-2757. (Pubitemid 37305637)
29. Nesse A, Garbossa G,. 2001. Aluminium toxicity in erythropoiesis, Mechanisms related to cellular dysfunction in Alzheimer's disease. In:, Exley C, editor. Aluminium and Alzheimer's disease. The science that describes the link. Amsterdam: Elsevier; pp 261-277.
30. Niemoeller O, Kiedaisch V, Dreischer P, Wieder T, Lang F,. 2006. Stimulation of eryptosis by aluminium ions. Toxicol Appl Pharmachol 217: 168-175. (Pubitemid 44708287)
31. O'Hare JA, Murnaghan DJ,. 1982. Reversal of aluminum induced hemodialysis anemia by low-aluminum dialyzate. N Engl J Med 306: 654-656. (Pubitemid 12192883)
32. 2+-initiated lipid peroxidation in phospholipid liposomes by a lipophilic aluminum complex, aluminum acetylacetonate. Biochim Biophys Acta 1389: 141-149. (Pubitemid 28022474)
33. Oteiza PI, Fraga CG, Keen CL,. 1993. Aluminum has both oxidant and antioxidant effects in mouse brain membranes. Arch Biochem Biophys 300: 517-521. (Pubitemid 23225779)
34. Pérez G, Garbossa G, Di Risio C, Vittori D, Nesse A,. 2001. Disturbance of cellular iron uptake and utilisation by aluminium. J Inorg Biochem 87: 21-27.
35. Pérez G, Garbossa G, Sassetti B, Di Risio C, Nesse A,. 1999. Interference of aluminium on iron metabolism in erythroleukaemia K562 cells. J Inorg Biochem 76: 105-112.
36. Pérez G, Pregi N, Vittori D, Di Risio C, Garbossa G, Nesse A,. 2005. Aluminum exposure affects transferrin-dependent and -independent iron uptake by K562 cells. Biochim Biophys Acta 1745: 124-130. (Pubitemid 41111975)
37. 2+]i concentration in human erythrocytes incubated with lead. Toxicol In Vitro 24: 1338-1346.
38. Schoeder TM, Caspers ML,. 1996. Kinetics of aluminum-induced inhibition of delta-aminolevulinic acid dehydratase in vitro. Biochem Pharmacol 52: 927-931. (Pubitemid 26301895)
39. Sedman A,. 1992. Aluminium toxicity in childhood. Pediatr Nephrol 6: 383-393.
40. Soni MG, White SM, Flamm WG, Burdock GA,. 2001. Safety evaluation of dietary aluminum. Regul Toxicol Pharmacol 33: 66-79. (Pubitemid 32242948)
41. 3 on toad skin, human erythrocytes, and model cell membranes. J Inorg Biochem 75: 263-268.
42. Touam M, Martínez F, Lacour B, Bourdon R, Zingraff J, Di Giulio S, Drüeke T,. 1983. Aluminium-induced, reversible microcytic anemia in chronic renal failure: clinical and experimental studies. Clin Nephrol 19: 295-298. (Pubitemid 13054399)
43. Vittori D, Garbossa G, Lafourcade C, Pérez G, Nesse A,. 2002. Human erythroid cells are affected by aluminium. Alteration of membrane band 3 protein. Biochim Biophys Acta 1558: 142-150. (Pubitemid 34075529)
44. Vittori D, Nesse A, Pérez G, Garbossa G,. 1999. Morphologic and functional alterations of erythroid cells induced by long-term ingestion of aluminium. J Inorg Biochem 76: 113-120.
45. Vittori D, Pregi N, Pérez G, Garbossa G, Nesse A,. 2005. The distinct erythropoietin functions that promote cell survival and proliferation are affected by aluminum exposure through mechanisms involving erythropoietin receptor. Biochim Biophys Acta 1743: 29-36. (Pubitemid 40380602)
46. Wills MR, Savory J,. 1983. Aluminium poisoning: Dialysis encephalopathy, osteomalacia, and anaemia. Lancet ii: 29-34. (Pubitemid 13060461)
47. Zatta P, Perazzollo M, Corain B,. 1989. Tris acetylacetonate aluminium (III) induces osmotic fragility and acanthocyte formation in suspended erythrocytes. Toxicol Lett 45: 15-21. (Pubitemid 19028261)